Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|November 13, 2003
Recombinant human laminin-5 domains. Effects of heterotrimerization, proteolytic processing, and N-glycosylation on alpha3beta1 integrin bindingKerstin Künneken, Gottfried Pohlentz, Alletta Schmidt-Hederich, et al.
Plos Pathogens|January 13, 2017
The Plasmin-Sensitive Protein Pls in Methicillin-Resistant Staphylococcus aureus (MRSA) Is a GlycoproteinIsabelle Bleiziffer, Julian Eikmeier, Gottfried Pohlentz, et al.
Scientific Reports|March 20, 2020
RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cellsIvan U Kouzel, Alexander Kehl, Petya Berger, et al.
Glycoconjugate Journal|January 8, 2008
Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicityChristian H Schweppe, Martina Bielaszewska, Gottfried Pohlentz, et al.
Journal of Lipid Research|December 19, 2012
Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cellsIvan U Kouzel, Gottfried Pohlentz, Wiebke Storck, et al.
Journal of Molecular and Cellular Cardiology|March 23, 2010
The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handlingUwe Kirchhefer, Diana Wehrmeister, Alex V Postma, et al.
Plos Biology|September 7, 2017
Correction: Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectivelyJohannes A Eble, Matthew McDougall, George L Orriss, et al.
Plos Biology|July 14, 2017
Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectivelyJohannes A Eble, Matthew McDougall, George L Orriss, et al.
Plos One|June 6, 2013
A new Mint1 isoform, but not the conventional Mint1, interacts with the small GTPase Rab6Anika Thyrock, Edith Ossendorf, Martin Stehling, et al.
Pageof 7